Gary W. Pace, Director at Cardiff Oncology, Inc. (CRDF), bought 361,615 shares at $2.60 ($940K) on 2024-12-11, disclosed to the SEC on 2024-12-12.
Open-market purchase of $940k CRDF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.60 | 11,500 | $30K | 3.2% |
| 2 | $2.60 | 350,115 | $910K | 96.8% |
| Total | $2.60 avg | 361,615 | $940K | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |
| CRDF | BUY | 2023-12-19 | $41K | — | Filing → |